Physician

Christopher Lee Colglazier, MD

According to 2025 Medicare claims, Christopher Colglazier, MD (NPI: 1679555486) practices rheumatology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is TRISTATE ARTHRITIS & RHEUMATOLOGY PSC (NPI: 1851449425; TIN: 611104130) and primary practice location at 41017-2418. Colglazier is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Colglazier's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 350 traditional Medicare patients, billed 144,654 HCPCS/CPT codes, and received $1,115,007 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,127 prescription claims across 472 beneficiaries totaling $1,518,073 in drug costs, led by Otezla (Apremilast). 2022 DME data shows 21 claims. Open Payments data shows 152 records totaling $3,063. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $699,003 to $1,115,007. Similarly, Part D prescription costs have risen steadily, from $923,636 to $1,518,073. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$645K$1.3M2015 Medicare payment: $699,003 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $844,294 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $872,303 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,010,866 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,226,245 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,186,816 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,290,098 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,126,378 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,093,055 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,115,007 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201543756,744$699,003
201645265,087$844,294
201745771,148$872,303
201848572,970$1,010,866
201952796,855$1,226,245
202049092,337$1,186,816
2021482102,393$1,290,098
2022414108,880$1,126,378
2023379119,930$1,093,055
2024350144,654$1,115,007

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.1M2015 Drug cost: $923,636 (USD; Tot_Drug_Cst)2016 Drug cost: $998,047 (USD; Tot_Drug_Cst)2017 Drug cost: $1,449,808 (USD; Tot_Drug_Cst)2018 Drug cost: $1,497,456 (USD; Tot_Drug_Cst)2019 Drug cost: $1,660,480 (USD; Tot_Drug_Cst)2020 Drug cost: $1,821,401 (USD; Tot_Drug_Cst)2021 Drug cost: $2,097,616 (USD; Tot_Drug_Cst)2022 Drug cost: $1,778,088 (USD; Tot_Drug_Cst)2023 Drug cost: $1,652,217 (USD; Tot_Drug_Cst)2024 Drug cost: $1,518,073 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155784,840$923,636
20165365,189$998,047
20175655,852$1,449,808
20185886,045$1,497,456
20196165,749$1,660,480
20206075,976$1,821,401
20216305,037$2,097,616
20225414,175$1,778,088
20234773,462$1,652,217
20244723,127$1,518,073

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.2K$2.3K2017 Medicare payment: $1,612 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,317 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,195 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$1,612
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R34$2,317
2021N/RN/RN/R
2022N/R21$1,195
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more7798$117
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more320671$86
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's253476$12
96372Injection of drug or substance under skin or into muscle149372$10
J1010Injection, methylprednisolone acetate, 1 mg14633,140$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast381,140$183,290
Humira PenAdalimumab24672$154,281
SimponiGolimumab15594$131,528
Orencia ClickjectAbatacept23644$112,022
RinvoqUpadacitinib12480$103,523

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.152$3,063ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Lee Colglazier, MD?

Tedicare shows public-source Medicare data for Christopher Lee Colglazier, MD (NPI 1679555486), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Lee Colglazier, MD have ACO affiliation data?

Christopher Lee Colglazier, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Christopher Lee Colglazier, MD?

Christopher Lee Colglazier, MD is linked to TRISTATE ARTHRITIS & RHEUMATOLOGY PSC (billing NPI 1851449425) in the available physician profile data.

Does Christopher Lee Colglazier, MD have Open Payments data?

Christopher Lee Colglazier, MD has 152 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.